Maged Shenouda, CFO of Relmada Therapeutics RLMD, has filed 11 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $1.1M. The latest trade was on 25/12/15.

MS

MS

Maged Shenouda

CFO

Company

Relmada Therapeutics RLMD

First filing

23/05/30

Trades

17 trades

Buys / sales

11 / 0

12-month net buying

$1.1M

Last trade

25/12/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Relmada TherapeuticsRLMD	Open-market buy	25/12/15	25/12/16	11,665 sh	$4.12	$48,059.8	+1.5%
Relmada TherapeuticsRLMD	Open-market buy	25/11/05	25/11/06	500,000 sh	$2.20	$1,100,000	+173.4%
Relmada TherapeuticsRLMD	Open-market buy	25/05/16–25/05/20	25/05/20	200,000 sh3 trades	$0.49avg.	$97,300	+226.4%
Relmada TherapeuticsRLMD	Open-market buy	24/09/09–24/09/11	24/09/11	53,432 sh3 trades	$2.80avg.	$149,700.84	+153.1%
Relmada TherapeuticsRLMD	Open-market buy	24/01/29–24/01/31	24/01/31	32,675 sh3 trades	$3.85avg.	$125,682.5	+1466.6%